Enprofylline
From Wikipedia, the free encyclopedia
 |
|
| Clinical data | |
|---|---|
| ATC code | None |
| Identifiers | |
|
|
| CAS Number | 41078-02-8  |
| PubChem (CID) | 1676 |
| DrugBank | DB00824  |
| ChemSpider | 1613 |
| UNII | DT7DT5E518 |
| KEGG | D04006 |
| ChEBI | CHEBI:126237 |
| ChEMBL | CHEMBL279898 |
| ECHA InfoCard | 100.050.166 |
| Chemical and physical data | |
| Formula | C8H10N4O2 |
| Molar mass | 194.190 g/mol |
| 3D model (Jmol) | Interactive image |
|
|
|
|
| (what is this?) (verify) |
|
Enprofylline (3-propylxanthine) is a xanthine derivative used in the treatment of asthma, which acts as a bronchodilator. It acts primarily as a competitive nonselective phosphodiesterase inhibitor with relatively little activity as a nonselective adenosine receptor antagonist.[1][2]
References[edit]
- ^ Lunell E, Svedmyr N, Andersson KE, Persson CG (1982). "Effects of enprofylline, a xanthine lacking adenosine receptor antagonism, in patients with chronic obstructive lung disease". European Journal of Clinical Pharmacology. 22 (5): 395–402. doi:10.1007/bf00542541. PMID 6288396.
- ^ Laursen LC (December 1987). "Anti asthmatic effects and pharmacokinetics of enprofylline--a new xanthine derivate". Danish Medical Bulletin. 34 (6): 289–97. PMID 3325233.
